TERT and Osteopenia: We further introduce a novel mechanism of MSC-EV therapy for osteopenia treatment; the administrated MSC-EVs are involved in rejuvenizing the tissue-specific microenvironmental modulating function of recipient bone marrow MSCs (BMMSCs) through promoting Tert gene expression and telomerase activity, resulting in exerting the bone mineral recovery in osteopenia model animals.